File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018

TitleMiddle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018
Authors
Abbad, APerera, RAPMAnga, LFaouzi, AMinh, NNTMalik, SMMRIounes, NMaaroufi, AVan Kerkhove, MDPeiris, MNourlil, J
Keywordsabattoir worker
adolescent
adult
aged
blood sampling
Issue Date2019
PublisherEuropean Centre for Disease Prevention and Control. The Journal's web site is located at http://www.eurosurveillance.org/Public/AboutUs/AboutUs.aspx
Citation
Eurosurveillance, 2019, v. 24 n. 48, p. article no. 1900244 How to Cite?
DOI: http://dx.doi.org/10.2807/1560-7917.ES.2019.24.48.1900244
AbstractBackground Middle East respiratory syndrome coronavirus (MERS-CoV) remains a major concern for global public health. Dromedaries are the source of human zoonotic infection. MERS-CoV is enzootic among dromedaries on the Arabian Peninsula, the Middle East and in Africa. Over 70% of infected dromedaries are found in Africa. However, all known zoonotic cases of MERS have occurred in the Arabian Peninsula with none being reported in Africa.
Persistent Identifierhttp://hdl.handle.net/10722/289539
ISSN
1025-496X
2023 Impact Factor: 9.9
2023 SCImago Journal Rankings: 2.881
ISI Accession Number ID
WOS:000499654500006

 

DC FieldValueLanguage
dc.contributor.authorAbbad, A-
dc.contributor.authorPerera, RAPM-
dc.contributor.authorAnga, L-
dc.contributor.authorFaouzi, A-
dc.contributor.authorMinh, NNT-
dc.contributor.authorMalik, SMMR-
dc.contributor.authorIounes, N-
dc.contributor.authorMaaroufi, A-
dc.contributor.authorVan Kerkhove, MD-
dc.contributor.authorPeiris, M-
dc.contributor.authorNourlil, J-
dc.date.accessioned2020-10-22T08:14:03Z-
dc.date.available2020-10-22T08:14:03Z-
dc.date.issued2019-
dc.identifier.citationEurosurveillance, 2019, v. 24 n. 48, p. article no. 1900244-
dc.identifier.issn1025-496X-
dc.identifier.urihttp://hdl.handle.net/10722/289539-
dc.description.abstractBackground Middle East respiratory syndrome coronavirus (MERS-CoV) remains a major concern for global public health. Dromedaries are the source of human zoonotic infection. MERS-CoV is enzootic among dromedaries on the Arabian Peninsula, the Middle East and in Africa. Over 70% of infected dromedaries are found in Africa. However, all known zoonotic cases of MERS have occurred in the Arabian Peninsula with none being reported in Africa.-
dc.languageeng-
dc.publisherEuropean Centre for Disease Prevention and Control. The Journal's web site is located at http://www.eurosurveillance.org/Public/AboutUs/AboutUs.aspx-
dc.relation.ispartofEurosurveillance-
dc.rightsEurosurveillance. Copyright © European Centre for Disease Prevention and Control.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectabattoir worker-
dc.subjectadolescent-
dc.subjectadult-
dc.subjectaged-
dc.subjectblood sampling-
dc.titleMiddle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018-
dc.typeArticle-
dc.identifier.emailPerera, RAPM: mahenp@hku.hk-
dc.identifier.emailPeiris, M: malik@hkucc.hku.hk-
dc.identifier.authorityPerera, RAPM=rp02500-
dc.identifier.authorityPeiris, M=rp00410-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.2807/1560-7917.ES.2019.24.48.1900244-
dc.identifier.pmid31796154-
dc.identifier.scopuseid_2-s2.0-85076014631-
dc.identifier.hkuros316980-
dc.identifier.volume24-
dc.identifier.issue48-
dc.identifier.spagearticle no. 1900244-
dc.identifier.epagearticle no. 1900244-
dc.identifier.isiWOS:000499654500006-
dc.publisher.placeSweden-
dc.identifier.issnl1025-496X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats